by Tom Wilemon
Some of the nation’s leading genitourinary cancer physicians will speak about the latest advances in care at an OncLive State of the Science Summit held in collaboration with Vanderbilt-Ingram Cancer Center.
Kimyrn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine, and Sam Chang, MD, MBA, Patricia and Rodes Hart Professor of Urologic Surgery, are co-chairs of the program. The State of the Science Summit: Treatment of Genitourinary Cancer is scheduled from 5 p.m. to 9 p.m. Wednesday, Nov. 13, at the Omni Nashville Hotel.
“This is a unique forum to discuss the most up-to-date treatment options for all urologic cancers and, importantly, includes all disciplines of care,” Chang said. “It’s intended for all cancer health care providers and will include lectures as well as panels and question and answer sessions.”
The presenters include several Vanderbilt physicians.
“The changes in kidney, bladder and prostate cancer treatments and outcomes have been tremendous in the past few years,” Rathmell said. “This is a great opportunity to update on those developments. It’s an unbelievably exciting time, and the options for patients are just exploding.”
Topics of discussion include:
- Novel Imaging in Advanced Prostate Cancer/New Management Strategies
- Treatment of Nonmetastatic Castrate-Resistant Prostate Cancer
- Advances in Metastatic Prostate Cancer
- Role of Radiation Therapy in Prostate Cancer
- Advanced Urothelial Cancer
- Newly Diagnosed Metastatic Renal Cell Carcinoma: Choosing Tyrosine Kinase Inhibitors or Immuno-Oncology Up Front
- Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma
- Peer Exchange: Panel Discussion and Q&A
The presenters include Katy Beckermann, PhD, MD; Daniel Barocas, MD, MPH, FACS; David Morris, MD, FACS; Eric Shinohara, MD, MSCI; Kelvin Moses, MD, PhD; Nancy Davis, MD; Kirk Keegan, MD, MPH; and David Penson, MD, MPH, MMHC.
